SALT Dental Partners: The Specialty-First DSO (2026)

In 2018 the platform now known as SALT Dental Partners ran a handful of pediatric and orthodontic offices in the Pacific Northwest. By late 2025 it spanned roughly 150 to 168 locations across 20 states, having tripled in size in about two years — one of the fastest growth curves in the dental support-organization space. For an investor reading the consolidated U.S. dental market, SALT is the rare platform that scaled fast while leading with specialty care rather than general dentistry, and that combination — pediatric-and-orthodontic backbone, multi-brand model, control-equity sponsor — is the whole story.

This profile is an independent assessment based on company disclosures, the private-equity sponsor's portfolio communications, industry rankings, and trade reporting. Where a figure comes directly from SALT, we say so; where it comes from an outside estimator or where sources disagree, we flag the hedge.

Overview

SALT is a doctor-led, multi-specialty dental support organization headquartered in the Phoenix, Arizona metropolitan area.¹ It partners with top-tier pediatric dentistry, orthodontic, oral and maxillofacial surgery, and general dentistry practices, providing centralized non-clinical infrastructure while leaving clinical decisions — and local practice brands — with the doctors.¹

A naming note matters up front. The underlying legal entity is SALT Dental Collective, LLC, the name the business was founded under and which still appears in formal filings; SALT Dental Partners is the primary commercial brand it adopted as it scaled and broadened into multiple specialties.¹ Early materials (roughly 2018–2022) called it "SALT Dental Collective"; the current website consistently uses "SALT Dental Partners."¹ The two are the same organization, not separate companies — worth fixing early because secondary databases sometimes treat them as distinct.

The business is a classic DSO in mechanics but pitches itself on a partnership ethos. SALT does not practice dentistry; it supplies operations, human resources, IT, recruiting, marketing, procurement, financial planning, and revenue-cycle support to dentist-owned practices, "built to accelerate your success — not change who you are."¹ What distinguishes it from many peers is that it built outward from a specialty core — pediatric dentistry and orthodontics — rather than from general dentistry, and that it preserves the acquired practices' local brands rather than rebranding everything under one banner.¹

Company Snapshot

• Founded: 2018, as SALT Dental Collective, originally a pediatric-and-orthodontic partnership in the Pacific Northwest and West (some business directories list 2019; the 2018 date traces to sponsor and company sources).²
• Headquarters: Phoenix / Scottsdale, Arizona (relocated from Bend, Oregon during its 2023 scale-up).²
• Model: Doctor-led, multi-specialty dental support organization — centralized non-clinical support to brand-preserving "partner" practices.¹
• Specialties: Pediatric dentistry and orthodontics (the core), plus oral and maxillofacial surgery and general dentistry.¹
• Practice locations: Approximately 150 to 168 (company-reported "150+" / "over 150"; an October 2025 transaction tally cited 168).³
• States: 20 (including Washington, D.C., per the company), up from five Western states at the start.⁴
• Doctors: Roughly 230 (company-reported 233 in spring 2025; an October 2025 third-party tally cited 228).⁴
• Brands: Roughly 65 distinct local practice brands (company-reported), reflecting a deliberate multi-brand strategy.⁴
• Current owner: Latticework Capital Management, a Dallas-based healthcare private-equity firm, as lead/controlling sponsor; additional financial sponsors include Resolute Capital Partners and GarMark Partners.⁵
• Revenue: Not company-disclosed; we do not publish an estimate (see Business Model).

Footprint Analysis

SALT's scale is best read as a fast-moving range, not a fixed number, because the network adds practices almost continuously and the unit being counted shifts between locations, practices, and brands.

The cleanest company-reported anchor is SALT's own spring-2025 growth statement, which laid out a two-year before-and-after: practice locations rose from 51 to 156 (a 206% gain), affiliated brands from 18 to 65 (261%), and doctors from 61 to 233 (282%), across 20 states including Washington, D.C.⁴ By that account SALT roughly tripled in scale in about two years. Industry recognition lines up: Becker's Dental + DSO Review named SALT one of its "44 DSOs to Know in 2025," describing it as a doctor-led, multi-specialty DSO with "more than 150 practices nationwide" that had "achieved more than 300% growth in two years and expanded into 20 states."³

Third-party transaction reporting pushes the most recent figure a little higher. An October 2025 tally of private-equity dental activity described SALT as operating approximately 168 practice locations across 20 states with about 228 doctors, in the context of three Mid-Atlantic acquisitions that month.³ The reasonable reading is that SALT supports on the order of 150 to 168 practice locations across 20 states and roughly 230 doctors, with the count drifting upward as new partnerships close.

Two distinctions matter when sizing the platform. Locations are not brands: the ~65 brand count is far lower than the location count because SALT runs multiple offices under shared local brands and preserves each acquired practice's name. And locations are not doctors: the ~230-doctor figure counts individual clinicians, not offices, so the three figures should not be conflated. SALT's homepage stat counters animate on load and can show partial mid-animation values, so the date-stamped company releases and trade tallies are the better anchors.

That scale places SALT firmly in the mid-tier of national DSOs — a genuine multi-state platform, but well below the 1,000-plus-office leaders and the diversified mid-large players (the Competitive Landscape section below sets out the field). What sets SALT apart there is less raw size than its specialty-first, pediatric-and-orthodontic identity.

Growth History

SALT's history reads as a two-act story: a regional specialty build-out, then a private-equity-driven national acceleration the company itself frames as "SALT 2.0."

Act one — the regional collective (2018–2022). SALT Dental Collective began around 2018 with roughly four locations, focused on pediatric dentistry and orthodontics across five Western states: Oregon, Washington, Idaho, Arizona, and California.² By 2021 it had reached about 26 locations across Washington and Oregon, and by late 2022 / early 2023 it counted nearly 60 affiliated practices in those five states — still specialty-focused, still regional.² Institutional capital entered during this phase: Latticework Capital Management's portfolio records reference an investment dating to 2019 (SALT is consistently described as "LCM-backed"), and Resolute Capital Partners has described an initial investment around March 2021. The precise sequencing and terms are not fully disclosed, as is typical for a private platform.⁵

Act two — "SALT 2.0" and national scale (2023–present). The inflection point was leadership. In January 2023 SALT named Dylan Bates chief executive officer, succeeding Jim Evanger; Bates, a multi-site healthcare operator who had previously led ATI Physical Therapy, had served on SALT's board for several years before taking the helm.² Under Bates the company relocated its home support office from Bend, Oregon to the Scottsdale/Phoenix area, professionalized its finance function, and built out functional leadership across operations, HR, IT, recruiting, marketing, procurement, and growth.⁵ Clinical leadership remained anchored by co-founder and chief dental officer Dr. Kolby Robinson, with the board adding outside clinical expertise to mentor emerging clinical leaders.²

The numbers followed. Per the sponsor's own portfolio update, SALT executed 19 strategic partnerships in 2023, adding roughly 40 locations and eight new states to reach 90-plus locations across 13 states by year-end, then pushed toward 150-plus locations nationwide through 2024.⁵ Crucially, 2024 also marked SALT's first move beyond pediatrics and orthodontics: it began adding oral and maxillofacial surgery in early 2024, and oral-surgery affiliations have continued (a Hampton Oral & Facial Surgery affiliation was advised to close in early 2026).⁵ Acquisition activity stayed brisk into late 2025, including a cluster of Mid-Atlantic pediatric and orthodontic practices.³

A point worth stating plainly, because it is a common source of confusion: SALT is not owned by Cobalt or by the Thurston Group. The available primary sources tie SALT's ownership to Latticework Capital Management as lead sponsor (with Resolute Capital Partners and GarMark Partners as additional financial sponsors); references linking SALT to "Cobalt" or to Thurston Group appear to be mix-ups with unrelated entities and other DSO platforms, and we found no documented ownership relationship to either.⁵ Likewise, while pediatric dentist Dr. Joshua Wren is sometimes named in informal commentary as SALT's founder, that attribution is not supported in the primary and near-primary sources we reviewed; the documented co-founder and clinical leader of record is Dr. Kolby Robinson.²

Business Model

SALT earns its return the way most DSOs do: by providing business and management services to the practices it supports, structured to capture a share of the efficiency it creates. It does not bill patients for clinical care — the dentist-owned practices do that — so SALT's economics rest on its support relationships, the scale advantages of centralized purchasing and back-office labor, and the growth it can unlock for partner practices.¹

Two features distinguish the model. The first is the specialty-first orientation. Where many large DSOs lead with general dentistry and bolt on specialties, SALT built from a pediatric-and-orthodontic backbone and layered in oral surgery and general dentistry around it.¹ That gives it tighter clinical adjacency — pediatric dentists, orthodontists, and oral surgeons share patient pathways, imaging, and sedation infrastructure — and a differentiated pitch to specialist doctors who may prefer a partner that understands their discipline. The second is the multi-brand, autonomy-preserving structure: SALT keeps roughly 65 local brands rather than consolidating under one national name, betting that community goodwill and existing patient relationships outweigh the marketing efficiency of a single banner.⁴

SALT does not publicly disclose revenue, and we are not publishing a third-party estimate. A widely circulated directory figure (around $33 million) reflects a much smaller, earlier stage of the company — before the network roughly tripled — and should not be read as current.³ Any model should treat SALT's top line as undisclosed and infer scale from its location, doctor, and brand counts instead.

Technology & Software Ecosystem

Public detail on SALT's core practice-management stack is thin, but its posture is that of a deliberately tech-enabled platform. Information technology sits among the functional areas SALT has staffed up at the corporate level, and the company describes its Phoenix-area home support office as a centralized "nerve center" coordinating a multi-state, multi-specialty network — the standardized, cloud-based practice-management and revenue-cycle infrastructure a 150-plus-location DSO effectively requires.⁵ The clearest specific signal is on the revenue-cycle side: SALT has been associated publicly with an AI-enabled revenue-cycle tool (referenced as "Remit AI") for automating claims and remittance work in high-volume pediatric and orthodontic billing.¹ That is illustrative of intent, not an exhaustive inventory — SALT does not disclose its full practice-management or imaging stack, so read it as the posture of a DSO standardizing operations and revenue tooling at scale.

Competitive Landscape

SALT competes in a heavily consolidated U.S. DSO market, and by raw office count it sits in the mid-tier rather than at the top. A rough hierarchy of national platforms by supported practice or office count runs:

• Heartland Dental — well over 1,800 offices; owned by KKR. The clear scale leader.
• Aspen Dental — more than 1,100 offices; backed by Leonard Green & Partners and Ares Management.
• PDS Health (formerly Pacific Dental Services) — around 1,000 offices; founder/dentist-owned at the platform level.
• Dental Care Alliance — roughly 400 multi-specialty allied practices; Harvest Partners and Mubadala.
• SALT Dental Partners — approximately 150 to 168 practice locations across 20 states; Latticework Capital Management.

That places SALT below the diversified mid-large platforms on size, but its distinguishing feature is the shape of its network, not its rank. Most large DSOs are general-dentistry-led; SALT is specialty-anchored in pediatrics and orthodontics, a segment with its own referral dynamics and, in pediatrics, meaningful Medicaid exposure. Among specialty-leaning and doctor-partnership platforms — a peer set that includes names like MB2 Dental's doctor-equity model and other pediatric/ortho consolidators — SALT's combination of rapid growth, multi-brand preservation, and a control-equity healthcare sponsor gives it a credible, differentiated position.

Market Position

SALT reads as a fast-growing, specialty-first platform that has compressed a decade's worth of DSO scaling into a few years. Its strengths are real: a genuine pediatric-and-orthodontic clinical identity that differentiates it from generalist consolidators, a multi-brand model that preserves the local goodwill specialist practices trade on, a professionalized leadership team under an experienced multi-site CEO, and a control-equity sponsor in Latticework with the capital to keep the buy-and-build engine running. Its recognition on Becker's "44 DSOs to Know in 2025" reflects that arrival.³

The pressures are the flip side of the speed. Integrating 100-plus practices across 20 states and four specialties in roughly two years strains corporate infrastructure, and the promise of clinical autonomy has to be reconciled, in practice, with the standardization a private-equity platform needs to capture synergies. The pediatric and orthodontic core carries payer-mix and policy sensitivity — pediatric dentistry in particular leans on Medicaid in many markets — so reimbursement shifts are a watch item. And as a sponsor-backed platform that has scaled aggressively, SALT's eventual capital path — a recapitalization, a larger sponsor, or a strategic exit — is the open question; the available sources show Latticework firmly in control as of late 2025 and into 2026, with no announced change.⁵ For an investor, the pace of integration and the sponsor's eventual exit timing are the things to watch.

TMR Take: For operators (specialists weighing affiliation): SALT's pitch is specialty-aware support and keeping your own brand — it built from a pediatric-and-orthodontic core, so a pediatric or orthodontic practice isn't an afterthought the way it can be inside a general-dentistry-led DSO. Diligence the support-fee structure, how much real clinical autonomy survives at scale, and how standardized the back-office systems are across 65-plus brands. For vendors: SALT buys at the platform level and has built centralized procurement and IT functions, so technology and supply decisions are made corporately rather than office by office — an efficient sell-in if you can clear one evaluation, but the multi-brand sprawl means understanding how uniform the stack actually is across the network. Its public lean toward AI-enabled revenue-cycle tooling signals appetite for operational software at scale. For investors: SALT is a mid-tier, specialty-first DSO (roughly 150–168 locations, ~230 doctors, 20 states) that tripled in about two years and is controlled by Latticework Capital Management, with earlier capital from Resolute Capital Partners. Get the ownership facts right: there is no documented link to Cobalt or the Thurston Group, and the founder attribution to Dr. Joshua Wren is unsupported — the clinical co-founder of record is Dr. Kolby Robinson. The watch items are integration risk at this growth pace, pediatric/Medicaid payer sensitivity, an undisclosed top line, and Latticework's eventual exit timing.

Sources

1. SALT Dental Partners — company website (positioning, specialties, model, and technology references).

2. SALT history and leadership — company and private-equity sponsor announcements (founding, CEO transition, headquarters relocation) and dental trade reporting.

3. Industry DSO rankings and sector reporting — Becker's Dental + DSO Review ("44 DSOs to Know in 2025"), DrBicuspid, and private-equity healthcare transaction reporting.

4. SALT Dental Partners — company growth disclosures (practice, brand, doctor, and state counts).

5. Ownership and growth — Latticework Capital Management portfolio communications and Resolute Capital Partners investment disclosures.